Pro Medicus Shares Rise After Signing Multi-Year Renewal with Allegheny Health Network (ASX: PME)

Pro Medicus Limited (ASX: PME) shares advanced on June 1, 2026, following the announcement of a multi-year contract renewal with U.S.-based Allegheny Health Network (AHN) for its Visage 7 enterprise imaging platform. The agreement extends the partnership and locks in recurring revenue from the hospital system. Financial terms were not disclosed. The renewal highlights AHN’s continued commitment to Pro Medicus’ technology across its hospitals and outpatient facilities. Pro Medicus shares rose as much as 4.2% in early ASX trading after the news, reaching A$126.80. The Melbourne-based company has steadily expanded its U.S. footprint, with the AHN contract contributing to a growing base of long-term academic medical center clients. The stock has climbed over 22% year-to-date through May 30, 2026, driven by contract wins and platform upgrades.